Cingulate (CING) is trading down at $4.75 (-0.21%), as of the latest quote. It operates in the Health Care sector.
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Operating income | −$7.08M | −$20.7M | −$17.5M | −$22.8M | −$15.6M | −$19.9M |
| Net income | −$7.18M | −$20.7M | −$17.7M | −$23.5M | −$16.6M | −$22.4M |
| EPS (diluted) | — | −$160704.00 | −$7044.00 | −$311.99 | −$10.86 | −$4.44 |
| Balance sheet | ||||||
| Cash and equivalents | $1.20M | $16.5M | $5.36M | $52.4K | $12.2M | $11.0M |
| Total assets | $5.79M | $22.9M | $11.4M | $3.49M | $14.9M | $15.1M |
| Total liabilities | $4.50M | $2.04M | $7.52M | $10.4M | $7.41M | $12.6M |
| Shareholders' equity | $1.29M | $20.8M | $3.88M | −$6.87M | $7.46M | $2.51M |
| Cash flow | ||||||
| Operating cash flow | −$6.81M | −$10.4M | −$15.9M | −$15.0M | −$18.5M | −$17.2M |
| Capital expenditure | $402.1K | $814.7K | $153.4K | $224.1K | $211.8K | $162.1K |
| Free cash flow | −$7.21M | −$11.2M | −$16.0M | −$15.3M | −$18.7M | −$17.4M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$3.28M | −$6.21M | −$3.71M | −$4.65M | −$6.00M | −$5.59M | −$7.92M | −$5.41M |
| Net income | −$4.13M | −$6.23M | −$3.85M | −$4.98M | −$7.34M | −$6.27M | −$9.31M | −$5.87M |
| EPS (diluted) | −$2.34 | $4.16 | −$1.06 | −$1.14 | −$1.35 | −$0.89 | −$0.95 | −$0.45 |
| Balance sheet | ||||||||
| Cash and equivalents | $10.0M | $12.2M | $9.52M | $8.90M | $6.12M | $11.0M | $25.9M | $28.4M |
| Total assets | $13.6M | $14.9M | $12.5M | $13.5M | $10.5M | $15.1M | $30.9M | $33.1M |
| Total liabilities | $1.54M | $7.41M | $6.54M | $7.96M | $7.05M | $12.6M | $12.0M | $9.60M |
| Shareholders' equity | $12.0M | $7.46M | $5.93M | $5.51M | $3.47M | $2.51M | $18.9M | $23.5M |
| Cash flow | ||||||||
| Operating cash flow | −$3.88M | −$4.08M | −$4.61M | −$4.80M | −$4.24M | −$3.60M | −$6.91M | −$5.90M |
| Capital expenditure | −$140.8K | $198.5K | — | — | $0 | $156.2K | $61.2K | $67.1K |
| Free cash flow | −$3.74M | −$4.28M | — | — | −$4.24M | −$3.75M | −$6.97M | −$5.97M |
From Cingulate's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Cingulate in our feed yet.